Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm

ClinicalTrials.gov ID: NCT01236768

Public ClinicalTrials.gov record NCT01236768. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 11:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Randomized, Phase 3 Study of the Contraceptive Efficacy and Safety of Agile Transdermal Contraceptive Delivery System in Comparison to an Oral Contraceptive (OC) Containing 150 mcg LNG and 30 mcg EE

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the efficacy and safety of a low dose transdermal contraceptive delivery system containing ethinyl estradiol and levonorgestrel.

Study identification

NCT ID
NCT01236768
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Agile Therapeutics
Industry
Enrollment
407 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 40 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2010 (Type not available)
Primary completion
Jun 2011 (Actual)
Completion
Jun 2011 (Actual)
Last update posted
Sep 15, 2017

2010 – 2011

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
Not listed Mobile Alabama 36608 —
Not listed Green Valley Arizona 85614 —
Not listed Tucson Arizona 85712 —
Not listed Los Angeles California 90036 —
Not listed Los Angeles California 90057 —
Not listed West Hills California 91307 —
Not listed Boynton Beach Florida 33472 —
Not listed South Miami Florida 33143 —
Not listed St. Petersburg Florida 33709 —
Not listed Newburgh Indiana 47630 —
Not listed Louisville Kentucky 40291 —
Not listed Las Vegas Nevada 89109 —
Not listed Las Vegas Nevada 89128 —
Not listed Kernersville North Carolina 27284 —
Not listed Englewood Ohio 45322 —
Not listed Tulsa Oklahoma 74105 —
Not listed Mt. Pleasant South Carolina 29464 —
Not listed Corpus Christi Texas 78414 —
Not listed Sugar Land Texas 77479 —
Not listed Newport News Virginia 23606 —
Not listed Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01236768, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2017 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01236768 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →